Wave Life Sciences (WVE) Operating Income (2016 - 2025)
Historic Operating Income for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$56.4 million.
- Wave Life Sciences' Operating Income rose 1183.13% to -$56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$135.9 million, marking a year-over-year increase of 1059.05%. This contributed to the annual value of -$110.4 million for FY2024, which is 6236.69% down from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Operating Income is -$56.4 million, which was up 1183.13% from -$52.8 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Operating Income ranged from a high of $23.0 million in Q4 2024 and a low of -$63.9 million during Q3 2024
- Its 5-year average for Operating Income is -$33.0 million, with a median of -$38.1 million in 2022.
- Examining YoY changes over the last 5 years, Wave Life Sciences' Operating Income showed a top increase of 22293.65% in 2024 and a maximum decrease of 153823.13% in 2024.
- Over the past 5 years, Wave Life Sciences' Operating Income (Quarter) stood at -$36.1 million in 2021, then decreased by 20.64% to -$43.6 million in 2022, then soared by 57.11% to -$18.7 million in 2023, then surged by 222.94% to $23.0 million in 2024, then crashed by 345.37% to -$56.4 million in 2025.
- Its Operating Income was -$56.4 million in Q3 2025, compared to -$52.8 million in Q2 2025 and -$49.8 million in Q1 2025.